Effect of left atrial appendage excision on procedure outcome in patients with persistent atrial fibrillation undergoing surgical ablation

详细信息    查看全文

• 作者：Alexander Romanov ; MD ; PhD ; FHRS^* ; ^{abromanov@mail.ru" class="auth_mail" title="E-mail the corresponding author} ; Evgeny Pokushalov ; MD ; PhD ; FHRS^* ; Dmitry Elesin ; MD^* ; Alexander Bogachev-Prokophiev ; MD^* ; Dmitry Ponomarev ; MD^* ; Denis Losik ; MD^* ; Sevda Bayramova ; MD^* ; Artem Strelnikov ; MD^* ; Vitaliy Shabanov ; MD^* ; Oleg Pidanov ; MD^&dagger ; ; Evgeny Kropotkin ; MD^&Dagger ; ; Eduard Ivanickii ; MD^&Dagger ; ; Alexander Karaskov ; MD ; PhD^* ; Jonathan S. Steinberg ; MD^§ ;
• 关键词：Atrial fibrillation ; Ablation ; Pulmonary vein ; Left atrial appendage
• 刊名：Heart Rhythm
• 出版年：2016
• 出版时间：September 2016
• 年：2016
• 卷：13
• 期：9
• 页码：1803-1809
• 全文大小：746 K

文摘

Catheter ablation is less successful for treatment of persistent atrial fibrillation (PersAF) than for paroxysmal atrial fibrillation. Some studies suggest that left atrial appendage (LAA) isolation in addition to pulmonary vein isolation (PVI) is required to maximize the benefits for PersAF after ablation.

Objective

The purpose of this study was to compare the efficacy and safety of 2 surgical ablation approaches for PersAF via video-assisted thoracoscopy: PVI + box lesion and PVI + box lesion + LAA excision.

Methods

We randomly assigned 176 patients with PersAF to video-assisted thoracoscopic surgical ablation with PVI + box lesion (88 patients) or PVI + box lesion + LAA excision (88 patients). The primary endpoint was freedom from any documented atrial arrhythmia lasting >30 seconds after a single ablation procedure without antiarrhythmic drug (AAD).

Results

After 18 months of follow-up, 61 of 86 patients (70.9%) assigned to PVI + box lesion were free from recurrent atrial fibrillation compared to 64 of 87 patients (73.6%) assigned to PVI + box lesion + LAA excision after a single ablation procedure without AAD (P = .73). Freedom from any atrial arrhythmia after a single procedure with or without AAD was also nonsignificant (70.9% vs 74.7%, respectively). There were no significant differences between groups with regard to adverse events, including death, transient ischemic attack, stroke, pneumothorax, and hydrothorax.

Conclusion

Among patients with PersAF, no reduction in the rate of recurrent atrial fibrillation was found when LAA excision was performed in addition to PVI and box lesion during surgical ablation.